Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.54 USD | +3.86% | -4.44% | -37.22% |
04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.22% | 591M | |
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
+28.34% | 11.79B | |
-30.70% | 11.95B |
- Stock Market
- Equities
- ACCD Stock
- News Accolade, Inc.
- Accolade Fiscal Q2 Loss Shrinks, Revenue Rises; Company Issues Fiscal Q3 Revenue Guidance